Standout Papers

Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lympho... 2002 2026 2010 2018 2.1k
  1. Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes (2002)
    Mark E. Dudley, John R. Wunderlich et al. Science
  2. Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes (2006)
    Richard A. Morgan, Mark E. Dudley et al. Science
  3. Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy (2011)
    Steven A. Rosenberg, James Chih‐Hsin Yang et al. Clinical Cancer Research
  4. Tumor antigen–specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired (2009)
    Mojgan Ahmadzadeh, Laura A. Johnson et al. Blood
  5. Cancer Immunotherapy Based on Mutation-Specific CD4+ T Cells in a Patient with Epithelial Cancer (2014)
    Eric Tran, Simon Turcotte et al. Science
  6. Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens (2008)
    Mark E. Dudley, James Chih‐Hsin Yang et al. Journal of Clinical Oncology
  7. A Phase I Study on Adoptive Immunotherapy Using Gene-Modified T Cells for Ovarian Cancer (2006)
    Michael H. Kershaw, Jennifer A. Westwood et al. Clinical Cancer Research
  8. PD-1 identifies the patient-specific CD8+ tumor-reactive repertoire infiltrating human tumors (2014)
    Alena Gros, Paul F. Robbins et al. Journal of Clinical Investigation
  9. Prospective identification of neoantigen-specific lymphocytes in the peripheral blood of melanoma patients (2016)
    Alena Gros, Maria R. Parkhurst et al. Nature Medicine
  10. A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response (2014)
    Paul F. Robbins, Sadik H. Kassim et al. Clinical Cancer Research
  11. Immunogenicity of somatic mutations in human gastrointestinal cancers (2015)
    Eric Tran, Mojgan Ahmadzadeh et al. Science
  12. Generation of Tumor-Infiltrating Lymphocyte Cultures for Use in Adoptive Transfer Therapy for Melanoma Patients (2003)
    Mark E. Dudley, John R. Wunderlich et al. Journal of Immunotherapy
  13. Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus–Targeted Tumor-Infiltrating T Cells (2015)
    Sanja Stevanović, Lindsey M. Draper et al. Journal of Clinical Oncology

Immediate Impact

15 by Nobel laureates 47 from Science/Nature 294 standout
Sub-graph 1 of 14

Citing Papers

Probiotic neoantigen delivery vectors for precision cancer immunotherapy
2024 StandoutNature
CAR immune cells: design principles, resistance and the next generation
2023 StandoutNature
54 intermediate papers

Works of John R. Wunderlich being referenced

A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1–Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
2014 Standout
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes
2002 StandoutScience
and 23 more

Author Peers

Author Last Decade Papers Cites
John R. Wunderlich 14596 15486 4734 121 20.7k
James C. Yang 11845 14905 5634 135 20.4k
Paul F. Robbins 21066 19940 8818 178 28.5k
Udai S. Kammula 10107 13715 4181 89 17.8k
Mark E. Dudley 19904 22980 6685 113 28.7k
Douglas J. Schwartzentruber 9736 8766 4782 81 16.1k
Richard M. Sherry 13589 18219 6035 96 24.6k
Richard A. Morgan 7938 13054 6922 120 18.3k
James L. Riley 12183 9451 3984 146 18.4k
Maryalice Stetler‐Stevenson 6069 8719 4234 228 15.4k
Patrick Hwu 9802 9200 4354 219 15.5k

All Works

Loading papers...

Rankless by CCL
2026